Tumor immunity in Ova-IC-nAPC treated mice was associated with higher accumulation of Ova-specific endogenous CD8+ T cells in draining lymph node and spleen compared to Ova-nAPC immunized mice (Fig. 4d). This evidence concerns the gene CD8A and neoplasm.